Amarantus BioScience

(OTC) AMBS

Current Price$0.00

Market Cap$600.00

Since IPO (2011)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Amarantus BioScience Financials at a Glance

Market Cap

$600.00

Revenue (TTM)

$96.61K

Net Income (TTM)

-$1.75M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

46.12 (High)

Dividend

$0.00

Beta (Volatility)

46.12 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.25

Estimated Earnings Date

Nov 25, 2024

Dividend

$0.00

Beta (Volatility)

46.12 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.25

Estimated Earnings Date

Nov 25, 2024

AMBS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amarantus BioScience

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Gerald E. Commissiong

Website

www.amarantus.com

Headquarters

New York City, NY 10005, US

AMBS Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-3%

Net Income Margin

-50%

Return on Equity

Return on Capital

Return on Assets

-47%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00

Shares Outstanding

630.41M

Volume

Avg. Volume

265.98K

Financials (TTM)

Gross Profit

$95.33K

Operating Income

-$268.00K

EBITDA

-$4.53M

Operating Cash Flow

-$4.50M

Capital Expenditure

$0.00

Free Cash Flow

-$4.50M

Cash & ST Invst.

$0.00

Total Debt

$19.14M

Amarantus BioScience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2023YOY CHG

Revenue

$1.28K

N/A

Gross Profit

$1.28K

N/A

Gross Margin

100.00%

N/A

Market Cap

$600.00

N/A

Market Cap/Employee

$50.00

N/A

Employees

N/A

Net Income

-$52.03K

+98.3%

EBITDA

-$60.00K

+98.0%

Quarterly Fundamentals

Name

Q1 2023YOY CHG

Total Cash

$0.00

-100.0%

Total Debt

$19.12M

-0.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$19.12M

-0.4%

Return on Assets

-46.65%

N/A

Return on Invested Capital

1.09%

N/A

Free Cash Flow

$7.97K

+100.3%

Operating Cash Flow

$7.97K

+100.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IBXGiBX Group, Inc.

IBXGiBX Group, Inc.$0.00+0.00%

ITMCItoco Inc.

ITMCItoco Inc.$0.00+0.00%

PRMDPrimemd Inc.

PRMDPrimemd Inc.$0.00+0.00%

ENDVEndonovo Therapeutics, Inc.

ENDVEndonovo Therapeutics, Inc.$0.00+0.00%

DECNDecision Diagnostics Corp.

DECNDecision Diagnostics Corp.$0.00+0.00%

AFFYAffymax, Inc.

AFFYAffymax, Inc.$0.00+10.00%

BSSPBaseline Productions, Inc.

BSSPBaseline Productions, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About AMBS

What is the current price of Amarantus BioScience?

Amarantus BioScience is trading at $0.00 per share.

What is the 52-week range for Amarantus BioScience?

Over the past 52 weeks, Amarantus BioScience has traded between $0.00 and $0.25.

How much debt does Amarantus BioScience have?

As of the most recent reporting period, Amarantus BioScience reported total debt of $19.14M.

How much cash does Amarantus BioScience have on hand?

Amarantus BioScience reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Amarantus BioScience’s dividend yield?

Amarantus BioScience does not currently have a dividend yield.

Amarantus BioScience

Amarantus BioScience Financials at a Glance

AMBS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Amarantus BioScience

AMBS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Amarantus BioScience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AMBS

What is the current price of Amarantus BioScience?

What is the 52-week range for Amarantus BioScience?

How much debt does Amarantus BioScience have?

How much cash does Amarantus BioScience have on hand?

What is Amarantus BioScience’s dividend yield?

Premium Investing Services